ISMRM/QIBA PDFF Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
<br />Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on February 3, 2022. | <br />Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on February 3, 2022. | ||
*[[Media:2023_01-26_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|January 26, 2023]] | |||
*[[Media:2022_02-03_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|February 3, 2022]] | *[[Media:2022_02-03_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|February 3, 2022]] | ||
*[[Media:2021_04-01_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|April 1, 2021]] | *[[Media:2021_04-01_QIBA_PDFF_BC_Meeting_Summary-FINAL.pdf|April 1, 2021]] | ||
'''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | '''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | ||
Revision as of 16:00, 21 December 2023
- Co-chairs: Diego Hernando, PhD; Houchun (Harry) Hu, PhD
- ISMRM Staff Support: Gerardo Mopera
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF. This effort is supported by ISMRM, using the QIBA Process for Profile development.
Meetings
Approved call summaries:
Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on February 3, 2022.
PDFF Biomarker Committee Call Summaries Archive